静脉注射的美托克洛普拉米德用于增加急性上部胃肠道出血的患者内镜粘膜可视化:一个多中心,随机,双盲,受控试验
Paveeyada Manupeeraphant1, Dhanusorn Wanichagool2, Thaphat Songlin3
1Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, 681 Samsen Road, Dusit District, Bangkok, 10300, Thailand.
前内镜静脉注射甲托克洛普拉米德显著改善了急性上部胃肠道出血 (UGIH) 患者的内镜粘膜可视化质量. 这种增强在活跃的水出血的情况下尤为明显,有助于更清晰的内镜评估.
科学领域:
- 胃肠病学 胃肠病学
- 内镜检查是指内镜检查.
- 临床试验 临床试验
背景情况:
- 急性上部胃肠道出血 (UGIH) 是一种常见的紧急情况,需要立即进行内镜干预.
- 有效的内镜粘膜可视化 (EMV) 对于UGIH的准确诊断和治疗至关重要.
- 预内镜剂在优化EMV质量的作用仍然是一个研究领域.
研究的目的:
- 评估前内镜静脉注射美托克洛普拉米德对急性UGIH患者EMV的影响.
- 评估梅托克洛普拉米德是否能在食道胃管腺镜检查期间改善可视化得分.
- 为了确定甲托克洛普拉米德是否有益于UGIH的特定病因,例如水出血.
主要方法:
- 进行了一项多中心,随机,双盲,安慰剂控制的试验.
- 患有急性UGIH的参与者在24小时内接受了食道胃管腺镜检查.
- 用修改的Avgerinos评分评估了内镜粘膜可视化,比较了美托克洛普拉米德和安慰剂组.
主要成果:
- 与安慰剂组相比,美托克洛普拉米德组的总EMV和胃体EMV得分显著更高.
- 两组之间没有观察到病变识别成功率的显著差异.
- 在患有活跃水出血的患者中,美托克洛普拉米德显著改善了胃,腹腔和总EMV得分.
结论:
- 前内镜静脉注射的甲托克洛普拉米德在急性UGIH中提高了内镜粘膜可视化质量.
- 这种益处在患有水出血的患者中最为明显,特别是那些有活跃出血迹象的患者.
- 梅托克洛普拉米德可能是改善特定UGIH病例内镜评估的宝贵补充剂.
更多相关视频
04:01Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
Published on: September 8, 2022
03:05Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
相关概念视频
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Endoscopic Procedures V: ERCP
Patient...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Endoscopic Procedures III: Video Capsule Endoscopy
